<svelte:head>
    <title>Multiple Antibiotic Resistant Coagulase Negative Staphylococci (MARCoNS) | mastcell.help | mastcell.help</title>
</svelte:head>

<div class="prose">

<h1 id="multiple-antibiotic-resistant-coagulase-negative-staphylococci-marcons">Multiple Antibiotic Resistant Coagulase Negative Staphylococci (MARCoNS)</h1>
<p>Multiple Antibiotic Resistant Coagulase Negative Staphylococci (MARCoNS) is a term used to describe a group of bacteria that belong to the genus Staphylococcus and are resistant to multiple antibiotics.</p>
<p><strong>Key points</strong>:</p>
<ul>
<li><p><strong>Staphylococcus Species</strong>: Staphylococci are a group of bacteria commonly found on the skin and mucous membranes. While some species are harmless or even beneficial, others can cause infections, especially in individuals with weakened immune systems.</p></li>
<li><p><strong>Antibiotic Resistance</strong>: Antibiotic resistance refers to the ability of bacteria to survive exposure to antibiotics, rendering the drugs less effective. MARCoNS specifically indicates that these coagulase-negative staphylococci have developed resistance to multiple antibiotics.</p></li>
<li><p><strong>Clinical Significance</strong>: While CoNS are generally considered opportunistic pathogens and may cause infections in certain situations, MARCoNS is of particular concern due to its resistance to commonly used antibiotics. This can complicate the treatment of infections caused by these bacteria.</p></li>
<li><p><strong>Association with Chronic Infections</strong>: MARCoNS is often associated with chronic infections, including chronic sinus infections. It has been identified in some cases where individuals experience persistent or recurrent infections that are challenging to treat.</p></li>
<li><p><strong>Biofilm Formation</strong>: Staphylococci, including CoNS, are capable of forming biofilms. Biofilms are protective structures that bacteria create, making them more resistant to antibiotics and the immune system. Biofilm formation can contribute to persistent infections.</p></li>
<li><p><strong>Treatment Challenges</strong>: Due to the antibiotic resistance of MARCoNS, treatment can be challenging. Healthcare providers may need to employ targeted antibiotic therapy based on sensitivity testing. Additionally, addressing biofilm formation and other contributing factors may be necessary.</p></li>
</ul>

</div>
